4.7 Editorial Material

Access to new drugs in paediatric oncology: can we learn from the ongoing ONC201 saga?

Journal

LANCET ONCOLOGY
Volume 24, Issue 3, Pages 209-212

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S1470-2045(23)00070-0

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available